Evidence map›Paper›PMID 39033026›Full record

Observational studyArchives of disease in childhood. Fetal and neonatal edition2025

Antibiotic use among extremely low birth-weight infants from 2009 to 2021: a retrospective observational study.

Dustin D Flannery, Alvaro Zevallos Barboza, Sagori Mukhopadhyay, Jeffrey S Gerber, Molly McDonough, Di Shu, Sean Hennessy, Kelly C Wade, Karen M Puopolo

Abstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Archives of disease in childhood. Fetal and neonatal edition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Observational
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Dustin D FlanneryNeonatology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA flanneryd@chop.edu.ORCID http://orcid.org/0000-0003-2883-4683
Alvaro Zevallos BarbozaNeonatology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Sagori MukhopadhyayNeonatology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Jeffrey S GerberPediatrics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Molly McDonoughCenter for Healthcare Quality & Analytics, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Di ShuBiostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Sean HennessyBiostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Kelly C WadeNeonatology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Karen M PuopoloNeonatology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.

Funding

AHRQ HHS K08 HS027468
6 · The paper itself

Abstract

objectiveTo assess trends in antibiotic use across a large cohort of extremely low birth-weight (<1000 g; ELBW) infants admitted to academic and community neonatal intensive care units (NICUs) across the USA over a 13-year period.

designRepeated cross-sectional cohort study.

settingPremier Health Database, a comprehensive administrative database of inpatient encounters from academic and community hospitals across the US. PATIENTS: ELBW inborn infants admitted to NICUs from 1 January 2009 to 31 December 2021.

interventionsN/A

main outcome measuresAbsolute and relative changes in (1) proportion of ELBW infants with antibiotic exposure and (2) days of therapy (DOT) per 1000 patient days, over time. Average annual differences were estimated using generalised linear regression with 95% CI. Disposition trends were also measured.

resultsAmong 36 701 infants admitted to 402 NICUs, the proportion exposed to antibiotics was essentially unchanged (89.9% in 2009 to 89.3% in 2021; absolute reduction of -0.6%); generalised linear regression estimated an annual absolute difference of -0.3% (95% CI (-0.6%) to (-0.07%); p=0.01). DOT per 1000 patient days decreased from 337 in 2009 to 210 in 2021, a 37.8% relative difference and annual relative difference of -4.3% ((-5.2%) to (-3.5%); p<0.001). Mortality was unchanged during the study period.

conclusionsWe found a substantial reduction in antibiotic DOT despite no substantive change in the proportion of infants exposed to antibiotics. This suggests the success of stewardship efforts aimed at antibiotic duration and highlight the need for improved approaches to identifying ELBW infants at highest risk of infection.

Indexed as

Anti-Bacterial AgentsInfant, Extremely Low Birth WeightCross-Sectional StudiesFemaleHumansInfant, NewbornIntensive Care Units, NeonatalMaleRetrospective StudiesUnited StatesAnti-Bacterial AgentsInfectious Disease MedicineIntensive Care Units, NeonatalNeonatologyPharmacology

Identifiers

PMID39033026
PMCPMC13192687

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.